Worth reading
15Immaterial
Scored from 3 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
0
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Monthly report on the exercise status of stock acquisition rights with an exercise price adjustment clause
発行・処分する株式数
Shares delivered during the month under review: 0 new shares and 0 treasury shares transferred
Terms of the stock acquisition rights
Exercise price
¥103 (on each exercise date during the month under review). The floor under the adjustment clause is Not disclosed.
Number of Stock Acquisition Rights
Total issued: 170,982; unexercised at month-end: 170,982; exercised during the month: 0
Procedures under the Corporate Code of Conduct
The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations. The number of shares delivered, aggregating all series, was 0, the number of listed shares at the time of payment for the issuance was 17,393,505, and the exercise ratio subject to the exercise restrictions was 0.00%.
Most recent equity financing
The acquisition and cancellation of Series 3 Stock Acquisition Rights, a third-party allotment of new shares, the issuance of Series 1 unsecured convertible bonds with stock acquisition rights, Series 2 unsecured convertible bonds with stock acquisition rights (with a conversion price adjustment clause), and Series 4 Stock Acquisition Rights (with an exercise price adjustment clause), all announced on 16 April 2026. The respective amounts were Not disclosed.
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly report on the exercise status of stock acquisition rights with an exercise price adjustment clause |
| Number of shares to be issued or disposed of | Shares delivered during the month under review: 0 new shares and 0 treasury shares transferred |
| Total number of issued shares | 17,393,505 shares (as of the end of the month preceding the month under review) → Not disclosed |
| Exercise price | ¥103 (on each exercise date during the month under review). The floor under the adjustment clause is Not disclosed. |
| Number of Stock Acquisition Rights | Total issued: 170,982; unexercised at month-end: 170,982; exercised during the month: 0 |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations. The number of shares delivered, aggregating all series, was 0, the number of listed shares at the time of payment for the issuance was 17,393,505, and the exercise ratio subject to the exercise restrictions was 0.00%. |
| Most recent equity financing | The acquisition and cancellation of Series 3 Stock Acquisition Rights, a third-party allotment of new shares, the issuance of Series 1 unsecured convertible bonds with stock acquisition rights, Series 2 unsecured convertible bonds with stock acquisition rights (with a conversion price adjustment clause), and Series 4 Stock Acquisition Rights (with an exercise price adjustment clause), all announced on 16 April 2026. The respective amounts were Not disclosed. |
Items this document does not state (21)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyDilution RateBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.No reason given by the company.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.